Latest News about HZNP
Recent news which mentions HZNP
   Stifel Nicolaus reduced Horizon Therapeutics (HZNP) PT to $138. HZNP is trading at $66.96
   
  August 03, 2022
  Tickers 
   HZNP
  
  
  From Best Stocks
 From Benzinga
 
   12 Health Care Stocks Moving In Wednesday's Intraday Session
   
  
  
  August 03, 2022
  From Benzinga
 
   Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  August 03, 2022
  From Benzinga
 
   Dow Jumps 350 Points; Crude Oil Drops Over 2%
   
  
  
  August 03, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Wednesday's Pre-Market Session
   
  
  
  August 03, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Horizon Therapeutics Begins Patient Enrolment in Phase 2 trial of Daxdilimab (HZN-7734) for Alopecia Areata
   
  May 17, 2022
  Tickers 
   HZNP
  
  
  From Benzinga
 From Benzinga
 
   Horizon Therapeutics' Inebilizumab Scores European Approval For Spinal Cord Inflammation
   
  May 02, 2022
  Tickers 
   HZNP
  
  
  From Benzinga
 From Benzinga
 
   Eton Pharmaceuticals Names James Gruber Finance Chief
   
  
  
  April 11, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.